EMD and/or Bone Substitute for the Treatment of Class II Furcations

Phase 4 Completed 41 enrolled University of Campinas, Brazil

RandomizedParallel-groupSingle-blindTreatment

Summary

To clinically evaluate the treatment of mandibular class II furcation defects with enamel matrix derivative (EMD) and/or a bone substitute graft make of beta tricalcium phosphate/hydroxyapatite (βTCP/HA).

Timeline

Start: 2013-03
Primary completion: 2014-12
Completion: 2015-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	EMD	Protein / enzyme biologic	—	—

EMD and/or Bone Substitute for the Treatment of Class II Furcations

Summary

Timeline

Drugs

Indications